# Vitruvian BioMedical, Inc. — Form D

Vitruvian BioMedical, Inc. of ADDISON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-03-15. The offering totals $4.0M, of which $25K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-03-15
- Form: D
- Accession: 0001693587-19-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $25K
- Remaining: $4.0M
- Minimum investment: $25K
- Investors: 1
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-334964

## Issuer

- Name: Vitruvian BioMedical, Inc.
- CIK: 0001693587
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 16475 DALLAS PARKWAY, SUITE 750, ADDISON, TX, TX
- Phone: 469-585-7513

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Arthur Bollon, PhD | Executive Officer | Addison, TX |

## More

- [CIK 1693587 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1693587&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001693587-19-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.